NORDIC BIOSITE ApS — Credit Rating and Financial Key Figures
CVR number: 30711572
Landgreven 3, 1301 København K
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 14 464.02 | 4 085.77 | 4 058.79 | 6 291.54 | 6 582.66 |
| Employee benefit expenses | -2 357.10 | -2 506.24 | -1 791.15 | -3 121.80 | -5 034.03 |
| EBIT | 12 106.92 | 1 579.52 | 2 267.64 | 3 169.75 | 1 548.63 |
| Other financial income | 0.21 | 0.03 | 1.40 | 2.97 | 5.17 |
| Other financial expenses | - 191.76 | -21.40 | -8.31 | -8.56 | -6.49 |
| Pre-tax profit | 11 915.38 | 1 558.16 | 2 260.72 | 3 164.16 | 1 547.31 |
| Income taxes | -2 645.92 | - 344.72 | - 494.71 | - 697.31 | - 341.65 |
| Net earnings | 9 269.46 | 1 213.44 | 1 766.01 | 2 466.84 | 1 205.66 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 2 044.92 | 2 448.53 | 4 602.33 | 2 438.04 | 2 202.48 |
| Current amounts owed by group member comp. | 8 225.12 | 345.66 | 3 488.48 | 1 734.45 | |
| Current other receivables | 9.37 | 11.28 | |||
| Current deferred tax assets | 48.88 | 241.86 | |||
| Short term receivables total | 10 270.03 | 2 448.53 | 4 996.87 | 5 935.89 | 4 190.07 |
| Cash and bank deposits | 6 372.43 | 1 391.02 | 955.77 | ||
| Cash and cash equivalents | 6 372.43 | 1 391.02 | 955.77 | ||
| Balance sheet total (assets) | 16 642.46 | 3 839.55 | 5 952.64 | 5 935.89 | 4 190.07 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 8 500.00 | 1 750.00 | 1 500.00 | 2 500.00 | 1 500.00 |
| Retained earnings | -8 208.32 | - 688.86 | - 975.42 | -1 709.41 | - 742.57 |
| Profit of the financial year | 9 269.46 | 1 213.44 | 1 766.01 | 2 466.84 | 1 205.66 |
| Shareholders equity total | 9 686.14 | 2 399.58 | 2 415.59 | 3 382.43 | 2 088.09 |
| Non-current liabilities total | |||||
| Advances received | 48.51 | 45.86 | 1.70 | ||
| Current trade creditors | 82.45 | 79.97 | 86.19 | 133.14 | 101.45 |
| Current owed to group member | 278.41 | 1 017.74 | 367.82 | ||
| Short-term deferred tax liabilities | 2 647.50 | 207.46 | 3.41 | ||
| Other non-interest bearing current liabilities | 4 177.86 | 828.26 | 2 431.42 | 2 049.09 | 2 000.53 |
| Current liabilities total | 6 956.32 | 1 439.97 | 3 537.05 | 2 553.46 | 2 101.98 |
| Balance sheet total (liabilities) | 16 642.46 | 3 839.55 | 5 952.64 | 5 935.89 | 4 190.07 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.